v3.26.1
INCOME TAXES
12 Months Ended
Dec. 31, 2025
Income Tax Disclosure [Abstract]  
INCOME TAXES

NOTE 16 – INCOME TAXES

 

At each reporting period, the Company considered all the positive and negative evidence related to the likelihood of realization of the deferred tax assets and determined, based on the weight of available evidence, it is more likely than not that some of the deferred tax assets will be realized. As of December 31, 2025 and 2024 the Company recorded $54.4 million and $47.0 million of deferred tax assets before valuation allowance, respectively, which was offset by $53.7 million and $47.0 million of valuation allowance, respectively. The Company has recorded net deferred tax liabilities of $11.4 million and $0 as of December 31, 2025 and 2024, respectively, which have all been determined to be sources of future taxable income. The increase of $6.7 million of the valuation allowance is based on cumulative negative operating results over the prior three-year period and expectations about generating U.S. taxable income in the future. The remaining valuation allowance relates primarily to anticipated expirations of U.S. net operating losses prior to utilization based on our forecasts of future taxable income.

 

(a) Composition of income before income taxes is as follows (in thousands):

 

SCHEDULE OF COMPOSITION OF INCOME BEFORE INCOME TAXES

         
   Year ended December 31, 
   2025   2024 
Pre Tax Book Loss          
Domestic  $(458,588)  $(10,339)
Foreign   (5,426)   - 
Total  $(464,014)  $(10,339)

 

 

Income tax (benefit) expense consists of the following (in thousands):

 

SCHEDULE OF INCOME TAX (BENEFIT) EXPENSE

         
   Year ended December 31, 
   2025   2024 
Current:        
Federal  $ -   $ - 
State   2    - 
Foreign   -    - 
Current income tax provision  $2   $- 
Deferred:          
Federal   (7,002)   - 
State and local   297    - 
Foreign   (1,257)   - 
Valuation allowance   6,706    - 
Net deferred income tax provision (benefit)   (1,256)   - 
Total income tax provision (benefit)   (1,254)   - 

 

For the years ended December 31, 2025 and 2024, the Company did not make any material cash payments for income taxes in the United States or foreign jurisdictions. Cash taxes paid during the periods presented were not material and primarily related to state minimum taxes and other non-income-based taxes.

 

(b) Effective Income Tax Rates

 

Set forth below is a reconciliation between the federal tax rate and the Company’s effective income tax rates with respect to continuing operations:

 

 SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION

         
   Year ended December 31, 
   2025   2025 
Expected income tax benefit at the U.S. federal statutory tax rate  $(97,443)   21%
State and local taxes, net of federal benefit(a)   2    -%
Foreign tax effects   (118)   -%
Effects of cross-border tax laws     -       - %
Research and development credits   110    -%
Changes in valuation allowance   9,075    (2)%
Nontaxable or nondeductible Items:          
Unrealized change in derivative value   80,360    (18)%
Stock based compensation   2,717    (1)%
Other   2,499    -%
Other Adjustments:          
Deferred tax adjustment   1,544    

-

%
Effective Tax Rate   (1,254)   -%

 

(a) For the year ended December 31, 2025, state taxes in the following states listed below made up a majority (greater than 50% of the tax effect of the state and local income taxes, net of federal taxes rate reconciliation line item).

 

Florida

 

The rate reconciliation above has been adjusted to be presented in compliance with the guidance under ASU 2023-09. The Company has adopted this guidance on a prospective basis.

 

 

As previously disclosed for the year ended December 31, 2024, prior to the adoption of ASU No. 2023-09, the following reconciles the federal tax rate and the Company’s effective income tax rates with respect to continuing operations:

 

  

Year ended

December 31, 2024

 
     
Statutory rate on pre-tax book loss   26%
Other   -%
Valuation allowance   (26)%
Effective income tax rates   -%

 

(c) Analysis of Deferred Tax Assets and (Liabilities) (in thousands):

 

 SCHEDULE OF ANALYSIS OF DEFERRED TAX ASSETS AND LIABILITIES

         
   As of December 31, 
   2025   2024 
Deferred tax assets (liabilities) consist of the following:    
Accruals  $360   $- 
Research & Development Costs   -    562 
Amortization Expense - Patents and Trademarks   10    - 
Unrealized Gain/Loss From Foreign Currency Exchange   163    - 
Nonqualified Stock Options   -    848 
Charitable Contributions   25    - 
163(j) Interest Expense Limitation   46    - 
Net Operating Loss Carryforwards   52,986    45,319 
Foreign Net Operating Loss Carryforward   697    - 
Research & Development Tax Credit   98    - 
Other Assets   -    252 
Total Deferred Tax Assets before Valuation Allowance   54,385    46,981 
Valuation Allowance   (53,686)   (46,981)
Total Deferred Tax Assets   699    - 
Depreciation Expense   (3)   - 
Foreign Acquisition of Intangible Assets Step Up   (12,117)   - 
Total deferred tax liabilities   (12,120)   - 
Net Deferred tax asset (liability)  $(11,421)  $- 

 

Valuation allowances relate primarily to NOL carryforwards related to the Company’s tax losses. During the years ended December 31, 2025 and 2024, the valuation allowance increased by $6.7 million and decreased by $8.4 million, respectively.

 

(d) Summary of Tax Loss Carryforwards

 

As of December 31, 2025, the Company had various NOL carryforwards expiring as follows (in thousands):

 

Expiration  Federal   State   Foreign 
2026-2031   961    657    - 
2032-2037   22,641    15,481    - 
2038-2045   -    -    2,512 
Unlimited   188,043    128,575    - 
Total  $211,645   $144,713   $2,512 

 

Due to the Streamex Acquisition, the utilization of the Company’s pre-2025 federal and state net operating losses may be subject to limitation under the Internal Revenue Code, as well as similar state provisions. Such limitations may result in the expiration of those net operating loss (NOL) carry forwards before their utilization. Future changes in the Company’s stock ownership, which may be outside of the Company’s control may trigger an “ownership change” which could result in limitations under the Internal Revenue Code.

 

 

The utilization of the Company’s net operating loss carryforwards and research tax credit carryovers could be subject to annual limitations under Sections 382 and 383 of the Internal Revenue Code of 1986, as amended (the “Code”), due to ownership change limitations that may have occurred previously or that could occur in the future. These ownership changes limit the amount of net operating loss carryforwards and other deferred tax assets that can be utilized to offset future taxable income and tax, respectively.

 

In general, an ownership change, as defined by Sections 382 and 383 of the Code, results from transactions increasing ownership of certain stockholders or public groups in the stock of a corporation by more than 50 percentage points over a three-year period. The Company has not completed a formal study to determine whether an ownership change under Sections 382 or 383 of the Code has occurred. To the extent that such a study is completed and an ownership change is deemed to have occurred, the Company’s ability to utilize its net operating loss carryforwards and tax credit carryovers could be significantly limited. The Company files income tax returns in the United States federal jurisdiction, various state jurisdictions, and Canada. The Company’s significant state tax jurisdictions include Florida.

 

The Company is no longer subject to U.S. federal income tax examinations for tax years ended on or before December 31, 2018. State income tax returns are generally subject to examination for periods ranging from three to five years, depending on the jurisdiction. Canadian income tax returns are generally subject to examination for three years following the date of assessment.

 

As of December 31, 2025, the Company is not currently under examination by any U.S. federal, state, or foreign tax authorities.

 

On July 4, 2025, the One Big Beautiful Bill was enacted (“OBBBA”), introducing significant and wide-ranging changes to the U.S. federal tax system. Significant components include restoration of 100% accelerated tax depreciation on qualifying property including expansion to cover qualified production property. Another major aspect includes the return to immediate expensing of domestic research and experimental expenditures (“R&E”) which in some cases may include retroactive application back to 2021 for businesses with gross receipts of less than $31 million or accelerated tax deductions of R&E that was previously capitalized for larger businesses. The legislation also reinstates EBITDA-based interest deductions for tax purposes and makes several business tax incentives permanent. Less favorable business provisions include limitations on tax deductions for charitable contributions.